SS Innovations Picks U.S.-Based Leaders For Surgical-Robot Expansion Pending Approvals

The new president will oversee U.S. and European market preparations while the company responds to FDA questions.

Share
SS Innovations Picks U.S.-Based Leaders For Surgical-Robot Expansion Pending Approvals

SS Innovations International, which makes and sells surgical robots, named U.S.-based leaders to prepare its business for American and European market entry pending regulatory approvals. The company announced the appointments Friday; an SEC filing put their effective date at November 6.

U.S. Preparations, With Review Still Underway

Dr. Vishwajyoti P. Srivastava, previously chief executive for Asia Pacific, became president and relocated to Denver, Colorado. Gary G. Lo joined as chief financial officer and will also work from the United States.

The president will coordinate efforts to secure permission to market the SSi Mantra surgical robot in the United States and European Union, and prepare operations for entry once approvals arrive. He is the son of Dr. Sudhir Srivastava, SS Innovations' chairman and chief executive.

The company is answering questions from the FDA about its premarket submission and pursuing European CE certification, according to its Friday announcement.

Sudhir Srivastava said the president would “build our US business and lead our global operations” during the next expansion phase.

An Installed Base Centered On India

SS Innovations sells systems to hospitals directly and through distributors, offering outright purchases, installment payments and pay-per-procedure arrangements. Instruments, accessories and services provide recurring revenue alongside system sales.

Its robots support specialties including urology, general surgery, gynecology, colorectal, thoracic and cardiac surgery. As of December 31, 2025, the company had installed 168 systems across 10 countries, including 154 in India. The systems had supported more than 7,800 procedures across 153 hospitals by that date.

The company also plans to introduce healthcare technologies being finalized at its India research facility in the coming months.

Robotics Financing Experience And Stock Options

Lo brings more than three decades of financial and executive experience. At Cellares, which develops robots for cell-therapy manufacturing, he led a $255 million financing in August 2023. His remit there included accounting, investor relations, human resources, procurement and information technology.

He subsequently served as CFO of Beyeonics Vision, which develops digital microscopes for eye surgery, and Subsense, which develops brain-computer interfaces. His earlier roles included Legrand, Sparta Systems, 1WorldSync, Johnson & Johnson, Siebel Systems, Boston Scientific and PwC. A certified public accountant, he holds degrees from the University of Chicago Booth School of Business and Boston College.

Lo's annual salary is $400,000, with a performance-based cash bonus targeting 50% of base pay. His agreement provides options to buy 500,000 shares at $2.11 each, vesting in four annual installments starting on the appointment's first anniversary, subject to continued employment. The options expire after 10 years.

If the company dismisses Lo without cause, he can receive three months of base salary before that first anniversary or six months thereafter, subject to signing a release. The board increased the president's base salary to $500,000.

SS Innovations is negotiating the remaining terms of the president's new employment agreement and plans to publish it once signed.

Sources

More on SS Innovations International

All SS Innovations International (SSII) coverage →